These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 10506868

  • 1. [New fluoroquinolones and treatment of acute sinusitis].
    Gehanno P, Trémolières F.
    Presse Med; 1999 Sep 04; 28(25):1365. PubMed ID: 10506868
    [No Abstract] [Full Text] [Related]

  • 2. Antimicrobial activity, pharmacokinetics and clinical studies of balofloxacin (Q-35) in obstetrics and gynaecology.
    Cho N, Miyakawa Z, Kimura T, Shimizu A, Notake Y, Kunii K.
    Drugs; 1995 Sep 04; 49 Suppl 2():391-2. PubMed ID: 8549373
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The quinolones.
    Neu HC.
    Infect Dis Clin North Am; 1989 Sep 04; 3(3):625-39. PubMed ID: 2671143
    [Abstract] [Full Text] [Related]

  • 5. Premafloxacin: a projected veterinary use fluoro-quinolone with significant activity against multi-resistant gram-positive human pathogens.
    Zerva L, Marshall SA, Jones RN.
    J Antimicrob Chemother; 1996 Oct 04; 38(4):742-4. PubMed ID: 8937972
    [No Abstract] [Full Text] [Related]

  • 6. [The difluoroquinolone lomefloxacin--an broad spectrum antimicrobial drug].
    Padeĭskaia EN, Iakovlev VP.
    Antibiot Khimioter; 1998 Oct 04; 43(2):30-9. PubMed ID: 9551171
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria.
    Moros M, Coll R, Esteve M, Parés J, Xicota MA.
    Chemioterapia; 1987 Jun 04; 6(2 Suppl):149-51. PubMed ID: 3509373
    [No Abstract] [Full Text] [Related]

  • 9. [Apropos of the status of new fluoroquinolones in treatment of acute sinusitis].
    Beucler A, Garre M, Polonowski JM.
    Presse Med; 1999 Nov 27; 28(37):2040-1. PubMed ID: 10605473
    [No Abstract] [Full Text] [Related]

  • 10. Effectiveness of fluoroquinolones against gram-positive bacteria.
    Bush K, Goldschmidt R.
    Curr Opin Investig Drugs; 2000 Sep 27; 1(1):22-30. PubMed ID: 11249591
    [Abstract] [Full Text] [Related]

  • 11. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II, Lopatkin NA, Khodyreva LA, Kondrat'eva EM.
    Urol Nefrol (Mosk); 1998 Sep 27; (5):14-8. PubMed ID: 9820038
    [No Abstract] [Full Text] [Related]

  • 12. Fluoroquinolone antibacterials: SAR mechanism of action, resistance, and clinical aspects.
    Gootz TD, Brighty KE.
    Med Res Rev; 1996 Sep 27; 16(5):433-86. PubMed ID: 8865150
    [No Abstract] [Full Text] [Related]

  • 13. Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro.
    Brothers AM, Gibbs PS, Wooley RE.
    Vet Ther; 2002 Sep 27; 3(4):493-500. PubMed ID: 12584687
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Efflux pumps of gram-positive bacteria and resistance to fluoroquionolones].
    Egorov AM, Sazykin IuO.
    Antibiot Khimioter; 2001 Sep 27; 46(8):3-5. PubMed ID: 11871317
    [No Abstract] [Full Text] [Related]

  • 16. Overview of the fluoroquinolone antibiotics.
    Just PM.
    Pharmacotherapy; 1993 Sep 27; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [Abstract] [Full Text] [Related]

  • 17. In vitro and bactericidal activities of ABT-492, a novel fluoroquinolone, against Gram-positive and Gram-negative organisms.
    Almer LS, Hoffrage JB, Keller EL, Flamm RK, Shortridge VD.
    Antimicrob Agents Chemother; 2004 Jul 27; 48(7):2771-7. PubMed ID: 15215148
    [Abstract] [Full Text] [Related]

  • 18. In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates.
    Montanari MP, Mingoia M, Varaldo PE.
    Antimicrob Agents Chemother; 2001 Dec 27; 45(12):3616-22. PubMed ID: 11709353
    [Abstract] [Full Text] [Related]

  • 19. [Effectiveness of a new fluoroquinolone antibiotic avelox in the treatment of suppurative sinusitis].
    Egorov VI, Kozarenko AV.
    Vestn Otorinolaringol; 2002 Dec 27; (5):35-6. PubMed ID: 12524963
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.